Drug Enforcement Administration May 2009 – Federal Register Recent Federal Regulation Documents

Schedules of Controlled Substances: Placement of Tapentadol Into Schedule II
Document Number: E9-11933
Type: Rule
Date: 2009-05-21
Agency: Drug Enforcement Administration, Department of Justice
With the issuance of this final rule, the Deputy Administrator of the Drug Enforcement Administration (DEA) places the substance tapentadol, including its isomers, esters, ethers, salts and salts of isomers, esters and ethers whenever the existence of such isomers, esters, ethers, and salts is possible, into schedule II of the Controlled Substances Act (CSA). As a result of this rule, the regulatory controls and criminal sanctions of schedule II will be applicable to the manufacture, distribution, dispensing, importation, and exportation of tapentadol and products containing tapentadol.
Controlled Substances: Proposed Aggregate Production Quotas for 2010
Document Number: E9-11929
Type: Notice
Date: 2009-05-21
Agency: Drug Enforcement Administration, Department of Justice
This notice proposes initial year 2010 aggregate production quotas for controlled substances in schedules I and II of the Controlled Substances Act (CSA).
Schedules of Controlled Substances: Placement of Lacosamide into Schedule V
Document Number: E9-11927
Type: Rule
Date: 2009-05-21
Agency: Drug Enforcement Administration, Department of Justice
With the issuance of this final rule, the Deputy Administrator of the DEA places the substance lacosamide [(R)-2-acetoamido-N-benzyl- 3-methoxy-propionamide] and any material, compound, mixture, or preparation which contains any quantity of lacosamide into schedule V of the Controlled Substances Act (CSA). As a result of this rule, the regulatory controls and criminal sanctions of schedule V will be applicable to the manufacture, distribution, dispensing, importation and exportation of lacosamide.
Manufacturer of Controlled Substances; Notice of Registration
Document Number: E9-11623
Type: Notice
Date: 2009-05-19
Agency: Drug Enforcement Administration, Department of Justice
Patrick W. Stodola, M.D.; Revocation of Registration
Document Number: E9-10245
Type: Notice
Date: 2009-05-05
Agency: Drug Enforcement Administration, Department of Justice
Roy Chi Lung, M.D.; Revocation of Registration
Document Number: E9-10029
Type: Notice
Date: 2009-05-01
Agency: Drug Enforcement Administration, Department of Justice
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.